321 related articles for article (PubMed ID: 35351709)
1. Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study.
Peat G; Fylan B; Marques I; Raynor DK; Breen L; Olaniyan J; Alldred DP
BMJ Open; 2022 Mar; 12(3):e054279. PubMed ID: 35351709
[TBL] [Abstract][Full Text] [Related]
2. Person-centred deprescribing for patients living with frailty: a qualitative interview study and proposal of a collaborative model.
Peat G; Fylan B; Breen L; Raynor DK; Olaniyan J; Alldred DP
Int J Pharm Pract; 2023 May; 31(3):282-289. PubMed ID: 37068006
[TBL] [Abstract][Full Text] [Related]
3. Co-designing an intervention to improve the process of deprescribing for older people living with frailty in the United Kingdom.
Silcock J; Marques I; Olaniyan J; Raynor DK; Baxter H; Gray N; Zaidi STR; Peat G; Fylan B; Breen L; Benn J; Alldred DP
Health Expect; 2023 Feb; 26(1):399-408. PubMed ID: 36420768
[TBL] [Abstract][Full Text] [Related]
4. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
Keller MS; Carrascoza-Bolanos J; Breda K; Kim LY; Kennelty KA; Leang DW; Murry LT; Nuckols TK; Schnipper JL; Pevnick JM
BMJ Open; 2023 Feb; 13(2):e066234. PubMed ID: 36813499
[TBL] [Abstract][Full Text] [Related]
5. Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review.
Brunner L; Rodondi N; Aubert CE
BMJ Open; 2022 Dec; 12(12):e061686. PubMed ID: 36549739
[TBL] [Abstract][Full Text] [Related]
6. What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis.
Radcliffe E; Servin R; Cox N; Lim S; Tan QY; Howard C; Sheikh C; Rutter P; Latter S; Lown M; Brad L; Fraser SDS; Bradbury K; Roberts HC; Saucedo AR; Ibrahim K
BMC Geriatr; 2023 Sep; 23(1):591. PubMed ID: 37743469
[TBL] [Abstract][Full Text] [Related]
7. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
Evrard P; Pétein C; Beuscart JB; Spinewine A
Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
[TBL] [Abstract][Full Text] [Related]
8. Barriers and facilitators to deprescribing before surgery: A qualitative study of providers and older adults.
Lee JW; Jeong S; Han HR; Boyd CM; Perrin N; Simmons SF; Green AR; Taylor JL; Boucher HR; Szanton SL
Geriatr Nurs; 2023; 53():135-140. PubMed ID: 37540907
[TBL] [Abstract][Full Text] [Related]
9. Barriers and facilitators to opioid deprescribing among Advanced Nurse Practitioners: A qualitative interview study.
McCann C; McCauley CO; Harkin D
J Adv Nurs; 2024 Jun; 80(6):2500-2511. PubMed ID: 38082475
[TBL] [Abstract][Full Text] [Related]
10. Stakeholders' perspectives and experiences of the pharmacist's role in deprescribing in ambulatory care: A qualitative meta-synthesis.
Kassis A; Moles R; Carter S
Res Social Adm Pharm; 2024 Aug; 20(8):697-712. PubMed ID: 38685144
[TBL] [Abstract][Full Text] [Related]
11. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study.
AlRasheed MM; Alhawassi TM; Alanazi A; Aloudah N; Khurshid F; Alsultan M
Clin Interv Aging; 2018; 13():1401-1408. PubMed ID: 30122912
[TBL] [Abstract][Full Text] [Related]
12. Challenges and opportunities in creating a deprescribing program in the emergency department: A qualitative study.
Lee S; Bobb Swanson M; Fillman A; Carnahan RM; Seaman AT; Reisinger HS
J Am Geriatr Soc; 2023 Jan; 71(1):62-76. PubMed ID: 36258309
[TBL] [Abstract][Full Text] [Related]
13. Barriers, facilitators, and resources to opioid deprescribing in primary care: experiences of general practitioners in Australia.
Hamilton M; Mathieson S; Gnjidic D; Jansen J; Weir K; Shaheed CA; Blyth F; Lin CC
Pain; 2022 Apr; 163(4):e518-e526. PubMed ID: 33990105
[TBL] [Abstract][Full Text] [Related]
14. Barriers and Facilitators to the Deprescribing of Nonbenzodiazepine Sedative Medications Among Older Adults.
Kuntz J; Kouch L; Christian D; Peterson PL; Gruss I
Perm J; 2018; 22():17-157. PubMed ID: 29702055
[TBL] [Abstract][Full Text] [Related]
15. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
[TBL] [Abstract][Full Text] [Related]
16. Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study.
Abou J; Crutzen S; Tromp V; Heringa M; Van Marum R; Elders P; Taxis K; Denig P; Hugtenburg J
Drugs Aging; 2022 Mar; 39(3):209-221. PubMed ID: 35187614
[TBL] [Abstract][Full Text] [Related]
17. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
[TBL] [Abstract][Full Text] [Related]
18. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
[TBL] [Abstract][Full Text] [Related]
19. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
Alharthi M; Wright D; Scott S; Birt L
Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
[TBL] [Abstract][Full Text] [Related]
20. Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications.
Goyal P; Requijo T; Siceloff B; Shen MJ; Masterson Creber R; Hilmer SN; Kronish IM; Lachs MS; Safford MM
Drugs Aging; 2020 Feb; 37(2):125-135. PubMed ID: 31858449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
